Fanconi anemia gene variants in therapy-related myeloid neoplasms

Blood Cancer Journal

Volumn 5, Issue , 2015, Pages

  Voso, M T ^a,b   Fabiani, E ^a   Zang, Z ^c   Fianchi, L ^a   Falconi, G ^a   Padella, A ^d   Martini, M ^a   Li Zhang, S ^e   Santangelo, R ^a   Larocca, L M ^a   Criscuolo, M ^a   La Brocca, A ^a   Cutcutache, I ^e   Rozen, S ^e   Simonetti, G ^d   Manfrini, M ^d   Martinelli, G ^d   Hohaus, S ^a   Leone, G ^a   Tan, P ^e   Tenen, D G ^e   more..

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; FANCONI ANEMIA PROTEIN;

ACUTE MYELOBLASTIC LEUKEMIA; FANCONI ANEMIA; GENE MUTATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOME ANALYSIS; HUMAN; LETTER; MYELODYSPLASTIC SYNDROME; PREVALENCE; PYROSEQUENCING; THERAPY RELATED MYELOID NEOPLASM; ACUTE MYELOID LEUKEMIA; ADULT; AGED; DNA SEQUENCE; FEMALE; GENETIC ASSOCIATION STUDY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MALE; MIDDLE AGED; SECOND CANCER;

ADULT; AGED; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; POLYMORPHISM, GENETIC; SEQUENCE ANALYSIS, DNA;

EID: 84936762040     PISSN: None     EISSN: 20445385     Source Type: Journal    
DOI: 10.1038/bcj.2015.44     Document Type: Letter

References (15)

1. Pedersen-Bjergaard J, Andersen MK, Andersen MT, Christiansen DH. Genetics of therapy-related myelodysplasia and acute myeloid leukemia. Leukemia 2008; 22: 240-248.
2. Leone G, Fianchi L, Voso MT. Therapy-related myeloid neoplasms. Curr Opin Oncol 2011; 23: 672-680.
3. Felix CA, Walker AH, Lange BJ, Williams TM, Winick NJ, Cheung NK et al. Association of CYP3A4 genotype with treatment-related leukemia. Proc Natl Acad Sci USA 1998; 95: 13176-13181.
4. Naoe T, Takeyama K, Yokozawa T, Kiyoi H, Seto M, Uike N et al. Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/myelodysplastic syndrome and de novo acute myeloid leukemia. Clin Cancer Res 2000; 6: 4091-4095.
5. Ellis NA, Huo D, Yildiz O, Worrillow LJ, Banerjee M, Le Beau MM et al. MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility. Blood 2008; 112: 741-749.
6. Fabiani E, Fianchi L, Falconi G, Boncompagni R, Criscuolo M, Guidi F et al. The BCL2L10 Leu21Arg variant and risk of therapy-related myeloid neoplasms and de novo myelodysplastic syndromes. Leuk Lymphoma 2014; 55: 1538-1543.
7. Walden H, Deans AJ. The Fanconi anemia DNA repair pathway: structural and functional insights into a complex disorder. Annu Rev Biophys 2014; 43: 257-278.
8. Garaycoechea JI, Patel KJ. Why does the bone marrow fail in Fanconi anemia? Blood 2014; 123: 26-34.
9. Kee Y, D'Andrea AD. Molecular pathogenesis and clinical management of Fanconi anemia. J Clin Invest 2012; 122: 3799-3806.
10. Schulz E, Valentin A, Ulz P, Beham-Schmid C, Lind K, Rupp V et al. Germline mutations in the DNA damage response genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy related myeloid neoplasms. J Med Genet 2012; 49: 422-428.
11. Offman J, Gascoigne K, Bristow F, Macpherson P, Bignami M, Casorelli I et al. Repeated sequences in CASPASE-5 and FANCD2 but not NF1 are targets for mutation in microsatellite-unstable acute leukemia/myelodysplastic syndrome. Mol Cancer Res 2005; 3: 251-260.
12. Tischkowitz MD, Morgan NV, Grimwade D, Eddy C, Ball S, Vorechovsky I et al. Deletion and reduced expression of the Fanconi anemia FANCA gene in sporadic acute myeloid leukemia. Leukemia 2004; 18: 420-425.
13. Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med 2013; 368: 2059-2074.
14. Djuzenova CS, Rothfuss A, Oppitz U, Spelt G, Schindler D, Hoehn H et al. Response to X-irradiation of Fanconi anemia homozygous and heterozygous cells assessed by the single-cell gel electrophoresis (comet) assay. Lab Invest 2001; 81: 185-192.
15. Voso MT, Fabiani E, Fianchi L, Falconi G, Criscuolo M, Santangelo R et al. Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases. Leukemia 2013; 27: 982-985.